Councils - Heart Failure & Transplantation



Scientific Council on Heart Failure & Transplantation

NOT A COUNCIL MEMBER?

Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website where you can update your membership profile and join any of the 12 Scientific Councils.



JOIN IN THE DISCUSSION!

The Donor Selection and Management Forum is now live! Login to ISHLTConnect (members only) to access this newest community and other exciting discussions.



PAST COUNCIL MEETING:
Friday, April 7, 2017, 11:30 AM - 1:30 PM
in Grand Hall B of the Manchester Grand Hyatt Hotel, San Diego, CA, USA, during the ISHLT 37th Annual Meeting and Scientific Sessions



HFTX JOURNAL WATCH:

Visit the Journal Watch page where, each month, two assigned HFTX Council members select 1-2 best articles from peer reviewed journals and provide a concise summary and opinion.



ISHLT MONOGRAPH SERIES:

Order your copy of

•  MONOGRAPH VOLUME 3 Parts I and II: Advance Heart Failure

•  MONOGRAPH VOLUME 6: ISHLT Guidelines for the Care of Heart Transplant Recipients

Click HERE for details and ordering info.



ISHLT LINKS NEWSLETTER:

Issues focusing on Heart Failure & Transplantation:

December 2016
July 2016
February 2016
November 2015
June 2015: HFTX Council Year in Review
January 2015
October 2014
November 2013
August 2013
December 2012
September 2011 (PDF)





COUNCIL LEADERSHIP OPERATING BOARD
(Parentheses after name indicates year rotating off Board)


COUNCIL CHAIR:

Michael Pham, MD, MPH (2020)
California Pacific Medical Center
San Francisco, CA, USA
415-600-1051
phammx@sutterhealth.org

Dr. Michael Pham is the Medical Director of the Center for Advanced Heart Failure Therapies at Sutter Health. He received his medical degree from the University of California, San Francisco and completed a Master’s Degree in Public Health at the Harvard School of Public Health.  Dr. Pham trained in cardiology and advanced heart failure/transplantation at Stanford and was on the Stanford faculty for 11 years, where he served as the UNOS Primary Heart Physician and Associate Medical Director of the Heart Transplant Program.  His clinical and research interests focus on non-invasive assessment of cardiac allograft rejection, remote monitoring of heart failure patients, and process improvement in health care.



COUNCIL VICE CHAIR:

Jignesh Patel, MD, PhD (2022)
Cedars Sinai Heart Institute
Los Angeles, CA, USA
jignesh.patel@cshs.org

Jignesh Patel, MD, PhD, FACC, FRCP is Clinical Professor and Medical Director of the heart transplant program at Cedars-Sinai Heart Institute.   He earned his bachelor’s and medical degrees at the University of Cambridge and a doctorate in vascular biology and physiology at UCLA where he also completed his general cardiology fellowship. He subsequently served as Associate Medical Director of the heart transplant program at UCLA Medical Center before assuming his current position at Cedars-Sinai in 2000.  He serves as Chair of the Transplant Committee at the Comprehensive Transplant Center at Cedars-Sinai and Director for Research in heart transplantation. His research focuses on management of sensitized patients awaiting heart transplantation and antibody-mediated rejection. His participation in the International Consortium for Cardiac Amyloidosis Transplantation has increased his involvement in therapeutic trials for cardiac amyloidosis.



COUNCIL PAST CHAIR:

Monica M. Colvin, MD (2018)
University of Michigan Health System
Ann Arbor, MI, USA
mmcolvin@med.umich.edu

Dr. Monica Colvin received her medical degree from the University of Alabama. She completed her general cardiology fellowship at the University of Miami and Advanced Heart Failure Fellowship at the Cleveland Clinic. She recently joined the faculty at the University of Michigan after spending 12 years at the University of Minnesota where she served as the heart transplant director. She completed a master’s degree in Clinical Research at the University of Minnesota School of Public Health. She is currently Director of Heart Transplant Research and Heart Failure Network Strategy at the University of Michigan. Her role as the heart clinical specialist for the Scientific Registry of Transplant Recipients has increased her involvement in heart allocation. Her research focuses on improving post-transplant outcomes and detecting and treating cardiac allograft vasculopathy.



BOARD OF DIRECTORS LIAISON:

Howard J. Eisen, MD, FAHA, FACC, FACP (2018)
Drexel University College of Medicine and Hahnemann University Hospital
Philadelphia, PA, USA
215-762-5080
Howard.Eisen@DrexelMed.edu

Howard J. Eisen, MD was born in Queens, New York and was graduated with an AB degree cum laude with distinction in all subjects and Phi Beta Kappa from the Cornell University College of Arts and Sciences in 1977. He received his MD from the University of Pennsylvania School of Medicine in 1981 and was elected to Alpha Omega Alpha. He did his Internal Medicine residency at the Hospital of the University of Pennsylvania. He then did his Cardiovascular Fellowship at Washington University in St. Louis/Barnes Hospital and completed this training in 1987. He was then an Assistant Professor of Medicine and Medical Co-Director of the Cardiac Transplant Program at the University of Pennsylvania. In 1993, he moved to the Temple University School of Medicine to be Medical Director of the Heart Failure and Cardiac Transplant Program which became one of the largest in the country. He rose to the rank of Professor of Medicine and Physiology at Temple. In 2005, Dr. Eisen was appointed Thomas J. Vischer Professor of Medicine and Chief of the Division of Cardiology at the Drexel University College of Medicine and Hahnemann University Hospital. He subsequently also was installed as the Joseph DiPalma MD Famaily Professor of Cardiology. Dr. Eisen is an Associate Editor of the American Journal of Transplantation and Transplantation and a Deputy editor the Journal of Clinical Transplantation. He is on the Editorial Board of the Journal of the American College of Cardiology Heart Failure,the Journal of Heart and Lung Transplantation and the Journal of Cardiac Failure. Dr. Eisen has led several clinical trials in cardiac transplant recipients including the everolimus clinical trials and has been involved in the development of gene expression profiling in cardiac transplant patients. He has chaired AHA research study sections and has been a member of NIH study sections. Dr. Eisen’s research has been funded by the American Heart Association of which he was an Established Investigator, the NIH and industry.



EDUCATION WORKFORCE LEADER:

Daniel H. Kim, MD (2020)
University of Alberta Medical School
Edmonton, AB, CANADA
780-407-7206
dk@ualberta.ca

Dr Kim is a Professor of Medicine at the University of Alberta and member of the Division of Cardiology at the Mazankowski Alberta Heart Institute where he is an Interventional & Heart Transplant Cardiologist. He is the Medical Director of Heart Transplantation and Medical Director of the Adult Cardiac Assist Devices Program. After graduating from the University of Calgary Medical School, Dr Kim went on to train in Internal Medicine, Cardiology and Interventional Cardiology at the University of Alberta. He then proceeded to do a Fellowship in Heart Transplantation and Advanced Heart Failure at the Stanford University Medical Center, in California. Since accepting an academic position at the University of Alberta in 2003, he has engaged in a busy academic clinical practice, while also dedicating himself to teaching, having received numerous teaching awards from the Faculty of Medicine & Dentistry, Department of Medicine, Department of Family Medicine, Cardiology Fellows, Internal Medicine Residents and the Medical Students Association. His clinical interests are in Acute Care, Advanced Heart Failure and Heart Transplantation, Mechanical Circulatory Support, as well as advanced cardiac procedures such as coronary interventions, invasive intracoronary imaging, coronary physiologic assessment and ECMO. His current research interests are non-invasive detection of acute and chronic rejection and cardiorenal physiology in heart failure.



I2C2 WORKFORCE LEADER:

Alejandro Bertolotti, MD (2018)
Favaloro Foundation
Buenos Aires, ARGENTINA
005491141428265
abertolotti@ffavaloro.org

Alejandro Mario Bertolotti, MD is Chairman of the Transplant Department,  Heart and Lung Transplant Divisions and of the General Thoracic Surgery Division at Hospital Universitario Fundación Favaloro, Buenos Aires, Argentina. He received his medical degree from Universidad Nacional de Rosario, Santa Fé Province, Argentina; and completed his Cardiovascular and Thoracic Surgery Training at ICyCC, Fundación Favaloro, Argentina. He is Member of the Advisory Committee of the Argentinean Central Unique National Institute Coordinator of Ablation and Implant, Incucai, where he has participated in the development of many related policies, such as the Heart and Lung Allocation Policies.

Dr Bertolotti has been engaged in clinical and preclinical research projects and device developments. He maintains an active participation in the academic and scientific areas, is Assistant Professor of the Department of Surgery, Universidad Favaloro. He has published papers in international peer reviewed journals and has been author and co-author of more than a hundred papers presented at national and international conferences




STANDARDS AND GUIDELINES COMMITTEE WORKFORCE LEADER:

Hannah Copeland, MD (2019)
Hunter Holmes McGuire VA Medical Center
Richmond, VA, USA
804-675-5000
hannahcopeland411@gmail.com

Bio coming soon...



ISHLT LINKS NEWSLETTER LIAISON:

David P. Nelson, MD
Integris Baptist Medical Center, Oklahoma City, OK, USA
405-949-3349
david.nelson@integrisok.com

Bio coming soon....



LIAISONS TO OTHER COUNCILS:

BSTR COUNCIL LIAISON:

Pradeep P.A. Mammen, MD, FACC, FAHA (2020)
UT Southwestern Medical Center
Dallas, Texas, USA
214-648-4994
pradeep.mammen@utsouthwestern.edu

Bio coming soon...



JFT COUNCIL LIAISON:

Natasha Altman, MD (Non-voting mentee through 2018)
University of Colorado
Denver, CO, USA
917-767-0878
natasha.altman@ucdenver.edu

Natasha L. Altman MD, FACC, received her medical degree from the University of Colorado School of Medicine in 2006. She completed both her residency and general cardiology fellowship training at the Mount Sinai School of Medicine in New York, NY, where she was Chief Cardiology Fellow.  She then completed her Advanced Heart Failure and Transplantation Fellowship at Cedars Sinai Medical Center.  She is currently an Assistant Professor at the University of Colorado Denver in the Section of Advanced Heart Failure, MCS and Transplantation. Her clinical and research interests include donor selection and management, invasive and implantable hemodynamic monitoring, and Heart Failure with Preserved Ejection Fraction.



Marco Masetti, MD, PhD (2018)
University of Bologna
Bologna, ITALY
39-339-746-3947
marcomasetti981@libero.it

Bio coming soon...



NHSAH COUNCIL LIAISON:

Edith Boyes, MSN, FNP-BC, CHFN
Loyola University Medical Center
Chicago, IL, USA
708-327-2086
eboyes@lumc.edu

Edith Boyes is an Advanced Heart Failure and Transplant Nurse Practitioner at Loyola University Medical Center in Maywood, Illinois. She received her BSN and MSN-FNP from Loyola University Chicago in 2010 and 2016, respectively. Her clinical specialty includes Advanced Heart Failure, Cardiac Transplantation, and Mechanical Circulatory Support. Edith previously worked as a VAD Coordinator for 4 years prior to becoming a nurse practitioner. Her research interests include VAD patient mortality and readmission.



COUNCIL LEADERSHIP OPERATING BOARD
(Parentheses after name indicates year rotating off Board)


COUNCIL CHAIR:

Michael Pham, MD, MPH (2020)
California Pacific Medical Center
San Francisco, CA, USA
415-600-1051
phammx@sutterhealth.org

Dr. Michael Pham is the Medical Director of the Center for Advanced Heart Failure Therapies at Sutter Health. He received his medical degree from the University of California, San Francisco and completed a Master’s Degree in Public Health at the Harvard School of Public Health.  Dr. Pham trained in cardiology and advanced heart failure/transplantation at Stanford and was on the Stanford faculty for 11 years, where he served as the UNOS Primary Heart Physician and Associate Medical Director of the Heart Transplant Program.  His clinical and research interests focus on non-invasive assessment of cardiac allograft rejection, remote monitoring of heart failure patients, and process improvement in health care.


COUNCIL VICE CHAIR:

Jignesh Patel, MD, PhD (2022)
Cedars Sinai Heart Institute
Los Angeles, CA, USA
jignesh.patel@cshs.org

Jignesh Patel, MD, PhD, FACC, FRCP is Clinical Professor and Medical Director of the heart transplant program at Cedars-Sinai Heart Institute.   He earned his bachelor’s and medical degrees at the University of Cambridge and a doctorate in vascular biology and physiology at UCLA where he also completed his general cardiology fellowship. He subsequently served as Associate Medical Director of the heart transplant program at UCLA Medical Center before assuming his current position at Cedars-Sinai in 2000.  He serves as Chair of the Transplant Committee at the Comprehensive Transplant Center at Cedars-Sinai and Director for Research in heart transplantation. His research focuses on management of sensitized patients awaiting heart transplantation and antibody-mediated rejection. His participation in the International Consortium for Cardiac Amyloidosis Transplantation has increased his involvement in therapeutic trials for cardiac amyloidosis.


COUNCIL PAST CHAIR:

Monica M. Colvin, MD (2018)
University of Michigan Health System
Ann Arbor, MI, USA
mmcolvin@med.umich.edu

Dr. Monica Colvin received her medical degree from the University of Alabama. She completed her general cardiology fellowship at the University of Miami and Advanced Heart Failure Fellowship at the Cleveland Clinic. She recently joined the faculty at the University of Michigan after spending 12 years at the University of Minnesota where she served as the heart transplant director. She completed a master’s degree in Clinical Research at the University of Minnesota School of Public Health. She is currently Director of Heart Transplant Research and Heart Failure Network Strategy at the University of Michigan. Her role as the heart clinical specialist for the Scientific Registry of Transplant Recipients has increased her involvement in heart allocation. Her research focuses on improving post-transplant outcomes and detecting and treating cardiac allograft vasculopathy.


BOARD OF DIRECTORS LIAISON:

Howard J. Eisen, MD, FAHA, FACC, FACP (2018)
Drexel University College of Medicine and Hahnemann University Hospital
Philadelphia, PA, USA
215-762-5080
Howard.Eisen@DrexelMed.edu

Howard J. Eisen, MD was born in Queens, New York and was graduated with an AB degree cum laude with distinction in all subjects and Phi Beta Kappa from the Cornell University College of Arts and Sciences in 1977. He received his MD from the University of Pennsylvania School of Medicine in 1981 and was elected to Alpha Omega Alpha. He did his Internal Medicine residency at the Hospital of the University of Pennsylvania. He then did his Cardiovascular Fellowship at Washington University in St. Louis/Barnes Hospital and completed this training in 1987. He was then an Assistant Professor of Medicine and Medical Co-Director of the Cardiac Transplant Program at the University of Pennsylvania. In 1993, he moved to the Temple University School of Medicine to be Medical Director of the Heart Failure and Cardiac Transplant Program which became one of the largest in the country. He rose to the rank of Professor of Medicine and Physiology at Temple. In 2005, Dr. Eisen was appointed Thomas J. Vischer Professor of Medicine and Chief of the Division of Cardiology at the Drexel University College of Medicine and Hahnemann University Hospital. He subsequently also was installed as the Joseph DiPalma MD Famaily Professor of Cardiology. Dr. Eisen is an Associate Editor of the American Journal of Transplantation and Transplantation and a Deputy editor the Journal of Clinical Transplantation. He is on the Editorial Board of the Journal of the American College of Cardiology Heart Failure,the Journal of Heart and Lung Transplantation and the Journal of Cardiac Failure. Dr. Eisen has led several clinical trials in cardiac transplant recipients including the everolimus clinical trials and has been involved in the development of gene expression profiling in cardiac transplant patients. He has chaired AHA research study sections and has been a member of NIH study sections. Dr. Eisen’s research has been funded by the American Heart Association of which he was an Established Investigator, the NIH and industry.


EDUCATION WORKFORCE LEADER:

Daniel H. Kim, MD (2020)
University of Alberta Medical School
Edmonton, AB, CANADA
780-407-7206
dk@ualberta.ca

Dr Kim is a Professor of Medicine at the University of Alberta and member of the Division of Cardiology at the Mazankowski Alberta Heart Institute where he is an Interventional & Heart Transplant Cardiologist. He is the Medical Director of Heart Transplantation and Medical Director of the Adult Cardiac Assist Devices Program. After graduating from the University of Calgary Medical School, Dr Kim went on to train in Internal Medicine, Cardiology and Interventional Cardiology at the University of Alberta. He then proceeded to do a Fellowship in Heart Transplantation and Advanced Heart Failure at the Stanford University Medical Center, in California. Since accepting an academic position at the University of Alberta in 2003, he has engaged in a busy academic clinical practice, while also dedicating himself to teaching, having received numerous teaching awards from the Faculty of Medicine & Dentistry, Department of Medicine, Department of Family Medicine, Cardiology Fellows, Internal Medicine Residents and the Medical Students Association. His clinical interests are in Acute Care, Advanced Heart Failure and Heart Transplantation, Mechanical Circulatory Support, as well as advanced cardiac procedures such as coronary interventions, invasive intracoronary imaging, coronary physiologic assessment and ECMO. His current research interests are non-invasive detection of acute and chronic rejection and cardiorenal physiology in heart failure.


I2C2 WORKFORCE LEADER:

Alejandro Bertolotti, MD (2018)
Favaloro Foundation
Buenos Aires, ARGENTINA
005491141428265
abertolotti@ffavaloro.org

Alejandro Mario Bertolotti, MD is Chairman of the Transplant Department,  Heart and Lung Transplant Divisions and of the General Thoracic Surgery Division at Hospital Universitario Fundación Favaloro, Buenos Aires, Argentina. He received his medical degree from Universidad Nacional de Rosario, Santa Fé Province, Argentina; and completed his Cardiovascular and Thoracic Surgery Training at ICyCC, Fundación Favaloro, Argentina. He is Member of the Advisory Committee of the Argentinean Central Unique National Institute Coordinator of Ablation and Implant, Incucai, where he has participated in the development of many related policies, such as the Heart and Lung Allocation Policies.

Dr Bertolotti has been engaged in clinical and preclinical research projects and device developments. He maintains an active participation in the academic and scientific areas, is Assistant Professor of the Department of Surgery, Universidad Favaloro. He has published papers in international peer reviewed journals and has been author and co-author of more than a hundred papers presented at national and international conferences



STANDARDS AND GUIDELINES COMMITTEE WORKFORCE LEADER:

Hannah Copeland, MD (2019)
Hunter Holmes McGuire VA Medical Center
Richmond, VA, USA
804-675-5000
hannahcopeland411@gmail.com

Bio coming soon...


ISHLT LINKS NEWSLETTER LIAISON:

David P. Nelson, MD
Integris Baptist Medical Center, Oklahoma City, OK, USA
405-949-3349
david.nelson@integrisok.com

Bio coming soon....


LIAISONS TO OTHER COUNCILS:

BSTR COUNCIL LIAISON:

Pradeep P.A. Mammen, MD, FACC, FAHA (2020)
UT Southwestern Medical Center
Dallas, Texas, USA
214-648-4994
pradeep.mammen@utsouthwestern.edu

Bio coming soon...

JFT COUNCIL LIAISON:

Natasha Altman, MD (Non-voting mentee through 2018)
University of Colorado
Denver, CO, USA
917-767-0878
natasha.altman@ucdenver.edu

Natasha L. Altman MD, FACC, received her medical degree from the University of Colorado School of Medicine in 2006. She completed both her residency and general cardiology fellowship training at the Mount Sinai School of Medicine in New York, NY, where she was Chief Cardiology Fellow.  She then completed her Advanced Heart Failure and Transplantation Fellowship at Cedars Sinai Medical Center.  She is currently an Assistant Professor at the University of Colorado Denver in the Section of Advanced Heart Failure, MCS and Transplantation. Her clinical and research interests include donor selection and management, invasive and implantable hemodynamic monitoring, and Heart Failure with Preserved Ejection Fraction.


Marco Masetti, MD, PhD (2018)
University of Bologna
Bologna, ITALY
39-339-746-3947
marcomasetti981@libero.it

Bio coming soon...

NHSAH COUNCIL LIAISON:

Edith Boyes, MSN, FNP-BC, CHFN
Loyola University Medical Center
Chicago, IL, USA
708-327-2086
eboyes@lumc.edu

Edith Boyes is an Advanced Heart Failure and Transplant Nurse Practitioner at Loyola University Medical Center in Maywood, Illinois. She received her BSN and MSN-FNP from Loyola University Chicago in 2010 and 2016, respectively. Her clinical specialty includes Advanced Heart Failure, Cardiac Transplantation, and Mechanical Circulatory Support. Edith previously worked as a VAD Coordinator for 4 years prior to becoming a nurse practitioner. Her research interests include VAD patient mortality and readmission.



Text SizeIncrease Font SizeDecrease Font Size